Correlation Between RepliCel Life and Quest PharmaTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RepliCel Life and Quest PharmaTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RepliCel Life and Quest PharmaTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RepliCel Life Sciences and Quest PharmaTech, you can compare the effects of market volatilities on RepliCel Life and Quest PharmaTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RepliCel Life with a short position of Quest PharmaTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of RepliCel Life and Quest PharmaTech.

Diversification Opportunities for RepliCel Life and Quest PharmaTech

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between RepliCel and Quest is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding RepliCel Life Sciences and Quest PharmaTech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quest PharmaTech and RepliCel Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RepliCel Life Sciences are associated (or correlated) with Quest PharmaTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quest PharmaTech has no effect on the direction of RepliCel Life i.e., RepliCel Life and Quest PharmaTech go up and down completely randomly.

Pair Corralation between RepliCel Life and Quest PharmaTech

Assuming the 90 days horizon RepliCel Life Sciences is expected to generate 11.76 times more return on investment than Quest PharmaTech. However, RepliCel Life is 11.76 times more volatile than Quest PharmaTech. It trades about 0.17 of its potential returns per unit of risk. Quest PharmaTech is currently generating about 0.11 per unit of risk. If you would invest  4.30  in RepliCel Life Sciences on August 30, 2024 and sell it today you would lose (4.09) from holding RepliCel Life Sciences or give up 95.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

RepliCel Life Sciences  vs.  Quest PharmaTech

 Performance 
       Timeline  
RepliCel Life Sciences 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in RepliCel Life Sciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting fundamental indicators, RepliCel Life reported solid returns over the last few months and may actually be approaching a breakup point.
Quest PharmaTech 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Quest PharmaTech are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Quest PharmaTech showed solid returns over the last few months and may actually be approaching a breakup point.

RepliCel Life and Quest PharmaTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RepliCel Life and Quest PharmaTech

The main advantage of trading using opposite RepliCel Life and Quest PharmaTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RepliCel Life position performs unexpectedly, Quest PharmaTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quest PharmaTech will offset losses from the drop in Quest PharmaTech's long position.
The idea behind RepliCel Life Sciences and Quest PharmaTech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments